Glycine for performance: biological promise, evidence remains limited

It participates in the synthesis of collagen, creatine and glutathione. But this still does not demonstrate that supplementing it improves athletes' performance or recovery.

On paper, few molecules seem to garner as many favorable arguments as glycine.

It participates in the formation of collagen, integrates the glutathione molecule, contributes to the synthesis of creatine and acts in nervous system signaling. For anyone looking at recovery, muscle mass, sleep and performance, the hypothesis is seductive.

The challenge lies in the distance between two different questions. The first is: Does glycine participate in processes relevant to the athlete? Yes. The second is: Does ingesting more glycine improve sports results? For this answer, the data is still insufficient.

A narrative review published in 2024 in the journal Sports brought together the mechanisms and studies used to support this promise. Reading is useful for mapping hypotheses. When each piece of evidence is separated by population, intervention, and design, however, practical application becomes much more limited. Ramos-Jiménez et al., 2024.

Editorial visualAn original scene created to expand the article's argument without replacing the evidence presented in the text.

Why the hypothesis makes sense

Glycine is an amino acid produced by the body and obtained from food. Its presence in different metabolic pathways helps explain its scientific interest.

In collagen, it occupies important structural positions. Glutathione makes up one of the main intracellular antioxidant systems. It also participates in the endogenous production of creatine and functions as a neurotransmitter or receptor modulator in the nervous system.

These mechanisms warrant research. They do not justify, in isolation, a recommendation.

Glycine molecule visually connected to collagen, muscle, glutathione and the nervous system.
PlausibilityGlycine participates in relevant pathways. Participating in biology, however, is not equivalent to improving a sporting outcome.
Between participating in a mechanism and improving performance there is an essential step: demonstrate the effect in humans.

What the evidence actually supports

The 2024 review is narrative. It does not present a reproducible search strategy, registered protocol, independent selection, formal assessment of risk of bias, or classification of the certainty of the evidence.

This does not make the work useless. This means that it should be read as an exploratory overview rather than a systematic review capable of establishing effectiveness.

Strength, power and endurance

Few direct data and part of the results come from compounds other than isolated glycine.

Very low
Recovery and hypertrophy

Predominance of cells, animals, patients, elderly people and combined interventions.

Very low
Subjective sleep

Small studies with 3 g before bed show positive signs, but with risk of bias.

Low
Prolonged use in high doses

There is no robust human basis for defining chronic efficacy or safety in athletes.

Unknown

A systematic review of glycine administration in adults came to a similar reading. Sleep studies in healthy people were small and had a high risk of bias. In the muscular area, there was no consistent improvement in strength or convincing prevention of muscle damage. Soh et al., 2024.

When the cited source does not answer the question

Scientific reading requires more than locating a positive sentence. It is necessary to verify which substance was used, who received the intervention and which comparison the design actually allows.

GPLC is not isolated glycine

The study used to discuss increased power in sprints administered 4.5 g of glycine propionyl-L-carnitine. It is a compound containing propionyl-L-carnitine, and its result cannot be automatically attributed to glycine. Jacobs et al., 2009.

GlyNAC has two components

Results obtained with glycine plus N-acetylcysteine do not reveal the isolated effect of either. The study cited was a small open trial with eight elderly people, without placebo and without randomization. Kumar et al., 2021.

The marathon did not have an inert placebo

In the 1999 work, glycine was compared with L-arginine, and not with the absence of supplementation. The study did not show prevention of muscle damage, but it also does not offer a clean estimate of glycine versus placebo.

Balance comparing many indirect studies with few direct studies on athletes.
Weight of evidenceMost of the promise comes from indirect models, clinical populations, or combined supplements. The direct base in athletes is still small.

Sleep is the most promising signal, though caution is still needed

Among the possible applications, sleep is the field in which there is a more coherent human signal. Small trials used approximately 3 grams of glycine before bed and observed improvement in some subjective measures of fatigue, sleep quality or performance the next day.

The size and design of these works prevent a firm conclusion. In one of the studies, ten men were included and only seven were included in the analysis during three nights of sleep restriction. Some outcomes improved; others do not. There was also involvement of researchers linked to the amino acid manufacturer Ajinomoto. This link does not invalidate the study, but it increases the need for independent replication. Bannai et al., 2012.

Therefore, there is a practical hypothesis. There is still no universal recommendation.

Athlete on night routine observing a small measure of glycine next to water and a diary.
Possible applicationUse before bed can be tested in a monitored manner. It does not replace sleep opportunity, environment, routine or caffeine control.
Argument map

How the ideas connect

Why the hypothesis makes sense
What the evidence actually supports
When the cited source does not answer the question
Sleep is the most promising signal, though caution is still needed
Mind mapA map of the relationships developed throughout the article.

Safety: less alarm, no license to overdo it

The review states that doses above 500 mg/kg could produce renal, hepatic or brain toxicity. One of the references used to support this concern, however, found something different.

Rats received 500, 1,000, or 2,000 mg/kg/day for four weeks. No changes considered toxicologically significant were observed, and the highest level tested was defined as the level without adverse effects observed in that model. Shibui et al., 2013.

This does not make 2,000 mg/kg a safe dose for people. Animal studies do not establish a human dose and the chronic safety of high doses remains poorly defined. The point is simpler: the toxicity limit presented by the review is not adequately supported by the reference itself.

Safety threshold

The absence of a serious signal in short studies does not equate to proven safety at high doses, for months, in athletes undergoing intense training.

What changes in practice

Performance and recovery

I would not include glycine as a priority supplement. There is not enough direct evidence of improvement in strength, power, endurance, hypertrophy or recovery.

Sleep

An individual experiment with about 3 g before bed can be considered in an appropriate context, with restrained expectation and monitoring of response and tolerance.

Before adding glycine, the criterion should be to check whether better sustained interventions are already organized:

  1. Energy and carbohydrates compatible with demand.Without sufficient availability, recovery starts from a much larger problem.
  2. Adequate and distributed protein.Quantity, quality and organization throughout the day have priority.
  3. Structured training and sleep.No amino acids compensate for poorly organized load or insufficient opportunity to sleep.
  4. Supplements with the best relationship between evidence and objective.Creatine monohydrate, for example, holds another position when the goal is strength and high-intensity performance.
  5. Product quality and traceability.Glycine does not appear by name on the 2026 Prohibited List, but athletes remain exposed to the risk of contamination from supplements.

A 2026 WADA Prohibited List has been in effect since January 1, 2026. For the tested athlete, independent certification and traceability remain part of the decision, even when the ingredient is not prohibited.

An update that still doesn't change the verdict

In 2025, a randomized, blinded trial administered 0.2 or 0.4 g/kg/day glycine to 29 critically ill patients for up to seven days. Glycine increased its concentrations in plasma and muscle, but had no effect on muscle fiber diameter. The quadriceps thickness estimate favored the higher dose, but remained imprecise and without a statistically significant difference. Abdelhamid et al., 2025.

The study deserves follow-up, but ventilated patients in intensive care do not represent healthy athletes. The result increases translational knowledge; does not establish an ergogenic effect.

Glycine remains a hypothesis, not a proven advantage

The biological importance of glycine is unquestionable. Its effectiveness as a sports supplement is not.

The review analyzed helps to explain why this molecule deserves to continue being investigated. At the same time, it mixes direct and indirect evidence in a way that can make the promise seem more mature than it actually is.

In high performance, an intervention should not gain ground just because it has an elegant mechanism. It needs to compete for attention, cost, adherence and complexity with strategies that have already demonstrated results.

Glycine deserves research. An athlete's routine still requires more discretion than enthusiasm.
Evidence base

Verified references

8 fonts
  1. Ramos-Jiménez A et al. · 2024An Update of the Promise of Glycine Supplementation for Enhancing Physical Performance and RecoverySports. 12(10):265 · DOI 10.3390/sports12100265
  2. Jacobs PL et al. · 2009Glycine propionyl-L-carnitine produces enhanced anaerobic work capacity with reduced lactate accumulation in resistance trained malesJournal of the International Society of Sports Nutrition. 6:9 PMID 19341458
  3. Kumar P et al. · 2021Glycine and N-acetylcysteine supplementation in older adults: results of a pilot clinical trialClinical and Translational Medicine. PMCID PMC8002905
  4. Bannai M et al. · 2012The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteersFrontiers in Neurology. 3:61 · DOI 10.3389/fneur.2012.00061
  5. Shibui Y et al. · 2013A 4-week repeated dose toxicity study of glycine in rats by gavage administrationJournal of Toxicologic Pathology. 26(4):405–412 · DOI 10.1293/tox.2013-0026
  6. World Anti-Doping Agency · 20262026 Prohibited ListList in force since January 1, 2026

Usage noteEducational content. The doses cited describe studied protocols or monitoring possibilities and do not replace individual nutritional assessment.

If this was worth your time, pass it on

Take this analysis to those who also need to make better decisions.

Share the article with athletes, coaches and professionals who can transform information into practice.

Return to Performance Journal

Performance Journal

Science to separate interesting mechanisms from truly sustained decisions.

View all articles